| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | cell morphogenesis | HSPG2 RELN NYAP2 ABL1 ABL2 MYCBP2 MYO10 L1CAM DOCK10 ALS2 PRAG1 ATP10A ADD1 CCDC88C HEG1 DST CELSR2 RNF6 PTPRJ NKX2-1 PKHD1 UNK MAEL FYN ULK2 FOXG1 RBFOX2 FOXD1 PROX1 | 8.33e-07 | 1194 | 184 | 29 | GO:0000902 |
| GeneOntologyBiologicalProcess | Wnt signaling pathway, planar cell polarity pathway | 9.37e-06 | 55 | 184 | 6 | GO:0060071 | |
| GeneOntologyBiologicalProcess | embryo development | A2M GPI HSPG2 SP3 FLT3LG ABL1 ABL2 KAT6A MAP3K20 CDK11A POU2F1 BIRC6 ADD1 FZD6 HOXB5 CELSR1 HEG1 HOXC6 BRCA2 CTR9 KMT2A SP9 UNK PBX1 KDM6A HCFC1 FOXG1 INVS PROX1 | 2.97e-05 | 1437 | 184 | 29 | GO:0009790 |
| GeneOntologyBiologicalProcess | negative regulation of cellular component organization | CARM1 HSPG2 SCAF8 IAPP RAP1GAP2 EML2 CEP192 PRAG1 KIF24 ADD1 CCDC88C ARHGAP6 RNF6 NDC80 NAV3 KMT2A CDK5RAP2 FYN CLEC16A ULK2 PCSK9 | 3.11e-05 | 864 | 184 | 21 | GO:0051129 |
| GeneOntologyBiologicalProcess | non-canonical Wnt signaling pathway | 6.51e-05 | 77 | 184 | 6 | GO:0035567 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle checkpoint | 9.90e-05 | 52 | 184 | 5 | GO:1901976 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle phase transition | UIMC1 MAP3K20 CEP192 TRRAP CLOCK NDC80 BRCA2 CRLF3 CDK5RAP2 GPNMB PROX1 | 1.15e-04 | 311 | 184 | 11 | GO:1901988 |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | GPI HSPG2 TCF4 SP3 RELN FLT3LG ABL1 COL15A1 ABL2 ANK2 KIAA0319L POU2F1 ADD1 FZD6 CELSR1 PTPN14 PANK2 PTPRJ NKX2-1 CTR9 GLUL AGFG1 AKAP13 TANC1 GPNMB KDM6A FOXD1 PROX1 | 1.31e-04 | 1483 | 184 | 28 | GO:0048646 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | HSPG2 RELN ABL1 ABL2 MYCBP2 L1CAM DOCK10 ALS2 DST CELSR2 RNF6 NKX2-1 UNK FYN ULK2 FOXG1 RBFOX2 FOXD1 | 1.34e-04 | 748 | 184 | 18 | GO:0048667 |
| GeneOntologyBiologicalProcess | microtubule polymerization or depolymerization | 1.36e-04 | 168 | 184 | 8 | GO:0031109 | |
| GeneOntologyBiologicalProcess | cell cycle checkpoint signaling | 1.49e-04 | 217 | 184 | 9 | GO:0000075 | |
| GeneOntologyBiologicalProcess | neuron migration | 1.54e-04 | 218 | 184 | 9 | GO:0001764 | |
| GeneOntologyBiologicalProcess | embryonic organ development | A2M HSPG2 SP3 FLT3LG KAT6A BIRC6 FZD6 HOXB5 CELSR1 KMT2A PBX1 KDM6A FOXG1 INVS PROX1 | 1.60e-04 | 561 | 184 | 15 | GO:0048568 |
| GeneOntologyBiologicalProcess | cell junction organization | RELN ABL1 ABL2 COL16A1 FRMPD4 ANK2 MYCBP2 L1CAM DOCK10 ALS2 ADD1 ARHGAP6 HEG1 DST PTPRJ SETD5 PKHD1 ADGRE5 TANC1 FYN GABRA4 | 1.69e-04 | 974 | 184 | 21 | GO:0034330 |
| GeneOntologyBiologicalProcess | chordate embryonic development | GPI HSPG2 SP3 ABL1 ABL2 CDK11A BIRC6 ADD1 FZD6 HOXB5 CELSR1 HEG1 HOXC6 BRCA2 CTR9 UNK PBX1 KDM6A HCFC1 PROX1 | 1.79e-04 | 906 | 184 | 20 | GO:0043009 |
| GeneOntologyBiologicalProcess | embryonic hemopoiesis | 1.81e-04 | 32 | 184 | 4 | GO:0035162 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | CARM1 UIMC1 TCF4 GRWD1 SMARCAL1 KAT6A LMNB2 TRRAP CLOCK BRCA2 SETD5 CTR9 MCM3AP KMT2A MAEL TAF4B MED23 TET3 KDM6A HCFC1 LRIF1 | 2.39e-04 | 999 | 184 | 21 | GO:0071824 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | GPI HSPG2 SP3 ABL1 ABL2 CDK11A BIRC6 ADD1 FZD6 HOXB5 CELSR1 HEG1 HOXC6 BRCA2 CTR9 UNK PBX1 KDM6A HCFC1 PROX1 | 2.48e-04 | 929 | 184 | 20 | GO:0009792 |
| GeneOntologyBiologicalProcess | Fc receptor mediated stimulatory signaling pathway | 2.59e-04 | 35 | 184 | 4 | GO:0002431 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle | THAP5 UIMC1 ABL1 MAP3K20 CEP192 TRRAP CLOCK NDC80 BRCA2 CRLF3 CDK5RAP2 GPNMB PROX1 | 2.83e-04 | 464 | 184 | 13 | GO:0045786 |
| GeneOntologyBiologicalProcess | motor neuron migration | 2.94e-04 | 15 | 184 | 3 | GO:0097475 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | HSPG2 RELN NYAP2 ABL1 ABL2 MYCBP2 L1CAM DOCK10 ALS2 DST CELSR2 RNF6 NKX2-1 FYN ULK2 FOXG1 RBFOX2 FOXD1 | 3.12e-04 | 802 | 184 | 18 | GO:0048812 |
| GeneOntologyBiologicalProcess | chromatin remodeling | CARM1 UIMC1 GRWD1 SMARCAL1 KAT6A LMNB2 CLOCK BRCA2 SETD5 CTR9 MCM3AP KMT2A MAEL TET3 KDM6A HCFC1 LRIF1 | 3.59e-04 | 741 | 184 | 17 | GO:0006338 |
| GeneOntologyBiologicalProcess | regulation of microtubule polymerization | 3.79e-04 | 69 | 184 | 5 | GO:0031113 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | HSPG2 RELN NYAP2 ABL1 ABL2 MYCBP2 L1CAM DOCK10 ALS2 DST CELSR2 RNF6 NKX2-1 FYN ULK2 FOXG1 RBFOX2 FOXD1 | 4.01e-04 | 819 | 184 | 18 | GO:0120039 |
| GeneOntologyBiologicalProcess | regulation of microtubule polymerization or depolymerization | 4.19e-04 | 108 | 184 | 6 | GO:0031110 | |
| GeneOntologyBiologicalProcess | negative regulation of cell cycle process | UIMC1 MAP3K20 CEP192 TRRAP CLOCK NDC80 BRCA2 CRLF3 CDK5RAP2 GPNMB PROX1 | 4.24e-04 | 362 | 184 | 11 | GO:0010948 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | HSPG2 RELN NYAP2 ABL1 ABL2 MYCBP2 L1CAM DOCK10 ALS2 DST CELSR2 RNF6 NKX2-1 FYN ULK2 FOXG1 RBFOX2 FOXD1 | 4.44e-04 | 826 | 184 | 18 | GO:0048858 |
| GeneOntologyBiologicalProcess | DN4 thymocyte differentiation | 4.69e-04 | 4 | 184 | 2 | GO:1904157 | |
| GeneOntologyBiologicalProcess | establishment of body hair planar orientation | 4.69e-04 | 4 | 184 | 2 | GO:0048105 | |
| GeneOntologyBiologicalProcess | establishment of body hair or bristle planar orientation | 4.69e-04 | 4 | 184 | 2 | GO:0048104 | |
| GeneOntologyBiologicalProcess | positive regulation of establishment of T cell polarity | 4.69e-04 | 4 | 184 | 2 | GO:1903905 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | A2M FLG HSPG2 RELN VWF COL15A1 COL16A1 L1CAM HRNR EDIL3 FREM1 EYS DST MUC17 LOXL1 LTBP3 PZP HCFC1 | 1.41e-06 | 530 | 187 | 18 | GO:0062023 |
| GeneOntologyCellularComponent | keratohyalin granule | 6.95e-06 | 5 | 187 | 3 | GO:0036457 | |
| GeneOntologyCellularComponent | extracellular matrix | A2M FLG HSPG2 RELN VWF COL15A1 COL16A1 L1CAM HRNR EDIL3 FREM1 EYS DST MUC17 LOXL1 LTBP3 PZP HCFC1 | 2.60e-05 | 656 | 187 | 18 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | A2M FLG HSPG2 RELN VWF COL15A1 COL16A1 L1CAM HRNR EDIL3 FREM1 EYS DST MUC17 LOXL1 LTBP3 PZP HCFC1 | 2.71e-05 | 658 | 187 | 18 | GO:0030312 |
| GeneOntologyCellularComponent | external side of plasma membrane | FCRL2 FLT3LG VWF L1CAM MUC16 IDE HEG1 MUC17 PKHD1 SCNN1B ADGRE5 PLAUR FCRL5 PCSK9 | 2.51e-04 | 519 | 187 | 14 | GO:0009897 |
| GeneOntologyCellularComponent | microtubule end | 3.61e-04 | 38 | 187 | 4 | GO:1990752 | |
| GeneOntologyCellularComponent | nuclear chromosome | 4.87e-04 | 254 | 187 | 9 | GO:0000228 | |
| GeneOntologyCellularComponent | CLOCK-BMAL transcription complex | 7.82e-04 | 5 | 187 | 2 | GO:1990513 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 7.94e-04 | 272 | 187 | 9 | GO:0090575 | |
| GeneOntologyCellularComponent | transcription regulator complex | CARM1 TCF4 SP3 POU2F1 TRRAP CLOCK ARID5A PRDM10 NKX2-1 TAF4B PBX1 MED23 MGA NPAS2 | 9.81e-04 | 596 | 187 | 14 | GO:0005667 |
| GeneOntologyCellularComponent | collagen trimer | 1.17e-03 | 88 | 187 | 5 | GO:0005581 | |
| MousePheno | spleen hypoplasia | 9.04e-06 | 128 | 149 | 9 | MP:0000694 | |
| MousePheno | abnormal pro-B cell morphology | 1.90e-05 | 78 | 149 | 7 | MP:0005432 | |
| MousePheno | decreased bone marrow cell number | 3.61e-05 | 86 | 149 | 7 | MP:0000333 | |
| MousePheno | abnormal B cell differentiation | TCF4 SP3 FLT3LG ABL1 INPP5D KAT6A MAP3K14 DOCK10 PTPRJ DCLRE1C KMT2A AKAP13 | 5.80e-05 | 287 | 149 | 12 | MP:0002144 |
| Domain | Laminin_G | 2.37e-05 | 58 | 186 | 6 | IPR001791 | |
| Domain | EGF_CA | 3.05e-05 | 122 | 186 | 8 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 3.42e-05 | 124 | 186 | 8 | IPR001881 | |
| Domain | ANK_REPEAT | POTEB3 ANK2 POTED MUC16 ANKHD1 POTEC ANKRD17 PLA2G6 TANC1 INVS AGAP1 | 4.82e-05 | 253 | 186 | 11 | PS50088 |
| Domain | ANK_REP_REGION | POTEB3 ANK2 POTED MUC16 ANKHD1 POTEC ANKRD17 PLA2G6 TANC1 INVS AGAP1 | 4.99e-05 | 254 | 186 | 11 | PS50297 |
| Domain | ASX_HYDROXYL | 6.37e-05 | 100 | 186 | 7 | PS00010 | |
| Domain | LamG | 7.36e-05 | 44 | 186 | 5 | SM00282 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 9.22e-05 | 106 | 186 | 7 | IPR000152 | |
| Domain | F_actin_bind | 9.86e-05 | 2 | 186 | 2 | PF08919 | |
| Domain | F-actin_binding | 9.86e-05 | 2 | 186 | 2 | IPR015015 | |
| Domain | FABD | 9.86e-05 | 2 | 186 | 2 | SM00808 | |
| Domain | Filaggrin | 9.86e-05 | 2 | 186 | 2 | IPR003303 | |
| Domain | EGF | 1.27e-04 | 235 | 186 | 10 | SM00181 | |
| Domain | EGF_3 | 1.27e-04 | 235 | 186 | 10 | PS50026 | |
| Domain | hEGF | 1.62e-04 | 28 | 186 | 4 | PF12661 | |
| Domain | EGF-like_dom | 2.04e-04 | 249 | 186 | 10 | IPR000742 | |
| Domain | ANK | POTEB3 ANK2 POTED ANKHD1 POTEC ANKRD17 PLA2G6 TANC1 INVS AGAP1 | 2.17e-04 | 251 | 186 | 10 | SM00248 |
| Domain | Ankyrin_rpt-contain_dom | POTEB3 ANK2 ANKHD1 POTEC ANKRD17 PLA2G6 AKAP13 TANC1 INVS AGAP1 | 2.39e-04 | 254 | 186 | 10 | IPR020683 |
| Domain | Ankyrin_rpt | POTEB3 ANK2 POTED ANKHD1 POTEC ANKRD17 PLA2G6 TANC1 INVS AGAP1 | 3.06e-04 | 262 | 186 | 10 | IPR002110 |
| Domain | SEA | 3.26e-04 | 14 | 186 | 3 | SM00200 | |
| Domain | Ank | 4.79e-04 | 228 | 186 | 9 | PF00023 | |
| Domain | LAM_G_DOMAIN | 5.39e-04 | 38 | 186 | 4 | PS50025 | |
| Domain | SAC3/GANP/THP3 | 5.84e-04 | 4 | 186 | 2 | IPR005062 | |
| Domain | SAC3_GANP | 5.84e-04 | 4 | 186 | 2 | PF03399 | |
| Domain | Laminin_G_2 | 6.58e-04 | 40 | 186 | 4 | PF02210 | |
| Domain | - | 8.74e-04 | 248 | 186 | 9 | 1.25.40.20 | |
| Domain | PHR | 9.67e-04 | 5 | 186 | 2 | IPR012983 | |
| Domain | PHR | 9.67e-04 | 5 | 186 | 2 | PF08005 | |
| Domain | EGF_1 | 1.06e-03 | 255 | 186 | 9 | PS00022 | |
| Domain | EGF-like_CS | 1.25e-03 | 261 | 186 | 9 | IPR013032 | |
| Domain | SEA | 1.30e-03 | 22 | 186 | 3 | PF01390 | |
| Domain | EGF_2 | 1.39e-03 | 265 | 186 | 9 | PS01186 | |
| Domain | Ank_2 | 1.44e-03 | 215 | 186 | 8 | PF12796 | |
| Domain | HELP | 1.44e-03 | 6 | 186 | 2 | PF03451 | |
| Domain | Lipase_euk | 1.44e-03 | 6 | 186 | 2 | IPR025483 | |
| Domain | Haem_d1 | 1.44e-03 | 6 | 186 | 2 | IPR011048 | |
| Domain | Abhydro_lipase | 1.44e-03 | 6 | 186 | 2 | PF04083 | |
| Domain | AB_hydrolase_lipase | 1.44e-03 | 6 | 186 | 2 | IPR006693 | |
| Domain | HELP | 1.44e-03 | 6 | 186 | 2 | IPR005108 | |
| Domain | SEA | 1.49e-03 | 23 | 186 | 3 | PS50024 | |
| Domain | SEA_dom | 1.49e-03 | 23 | 186 | 3 | IPR000082 | |
| Domain | Collagen | 1.60e-03 | 85 | 186 | 5 | IPR008160 | |
| Domain | Collagen | 1.60e-03 | 85 | 186 | 5 | PF01391 | |
| Domain | EGF | 1.65e-03 | 126 | 186 | 6 | PF00008 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HSPG2 ABL1 MYCBP2 MYO10 UBR4 L1CAM KAT6A KIAA0319L RAP1GAP2 EML2 CEP192 LMNB2 ANKHD1 TRRAP PRAG1 BIRC6 SLC29A2 CCDC88C CELSR1 HEG1 DST CELSR2 SETD5 MCM3AP PLA2G6 AKAP13 TANC1 LTBP3 ULK2 HCFC1 | 6.22e-13 | 1105 | 192 | 30 | 35748872 |
| Pubmed | FLG UIMC1 NOL4 HSPG2 TCF4 SCAF8 UBR4 CDK11A POU2F1 CEP192 HRNR VSX1 FLG2 ANKHD1 TRRAP DCAF5 LENG8 DST TNRC6A KMT2A ANKRD17 SP9 UNK GNB4 QSER1 PBX1 MGA KDM6A HCFC1 LRIF1 | 3.38e-10 | 1429 | 192 | 30 | 35140242 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | AMER1 ABL1 ABL2 MYCBP2 MAP3K14 MAP3K20 ALS2 CEP192 PRAG1 RGS12 CEP170 CCDC88C PTPN14 PANK2 DST PHF3 AGFG1 KMT2A ANKRD17 AKAP13 TANC1 DOP1A TPD52L1 | 5.29e-10 | 861 | 192 | 23 | 36931259 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | AMER1 MYCBP2 SCAF8 KAT6A CEP192 WDR25 IDE TRRAP ATP10A CEP170 ARHGAP6 PTPRJ SETD5 ANKRD17 PLA2G6 AKAP13 TANC1 GREB1 QSER1 CSMD1 PBX1 CATSPERG CLEC16A TET3 KDM6A RBFOX2 DOP1A INVS AGAP1 NPAS2 | 8.89e-10 | 1489 | 192 | 30 | 28611215 |
| Pubmed | FRMPD4 ZFYVE16 MYO10 SCAF8 DOCK10 RAP1GAP2 ALS2 CEP192 DCAF5 SETD5 PHF3 MCM3AP NAV3 CLEC16A ULK2 TET3 | 1.22e-09 | 407 | 192 | 16 | 12693553 | |
| Pubmed | THAP5 A2M UIMC1 HSPG2 VWF ZFYVE16 MYCBP2 UBR4 BTBD2 DST CTR9 MCM3AP GLUL LTBP3 GPNMB MGA KDM6A INVS | 6.05e-09 | 591 | 192 | 18 | 15231748 | |
| Pubmed | VWF ABL2 ZNF175 RAP1GAP2 LENG8 DST KIAA1549L MCM3AP TNRC6A GLUL NAV3 AGFG1 ANKRD17 AKAP13 MGA RBFOX2 | 1.49e-08 | 486 | 192 | 16 | 20936779 | |
| Pubmed | Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin. | 1.66e-07 | 3 | 192 | 3 | 23403047 | |
| Pubmed | DOT1L deletion impairs the development of cortical parvalbumin-expressing interneurons. | 4.31e-07 | 52 | 192 | 6 | 37566909 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | NOL4 DUXA POU2F1 HRNR FLG2 MCM3AP KMT2A QSER1 PBX1 MGA KDM6A LRIF1 | 6.73e-07 | 351 | 192 | 12 | 38297188 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | THAP5 TCF4 SP3 ZNF175 POU2F1 VSX1 CLOCK HOXB5 HOXC6 ZNF28 NKX2-1 KMT2A SP9 MAEL PBX1 MGA FOXG1 PROX1 NPAS2 | 7.86e-07 | 908 | 192 | 19 | 19274049 |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | A2M HSPG2 ABL1 DCAF4L2 ALS2 BIRC6 DST CASTOR1 CDK5RAP2 TAF4B MGA DCAF4 | 9.58e-07 | 363 | 192 | 12 | 14691545 |
| Pubmed | FLG NOL4 TCF4 IAPP ZNF175 CDK11A POU2F1 IDE ANKHD1 CLOCK PANK2 GNB4 TET3 KDM6A GABRA4 NPAS2 | 1.53e-06 | 686 | 192 | 16 | 29987050 | |
| Pubmed | CARM1 NYAP2 ANK2 MYCBP2 UBR4 DPYSL4 LMNB2 ADD1 CEP170 CCDC88C DST CELSR2 GLUL ANKRD17 CDK5RAP2 QSER1 MGA FOXG1 PROX1 | 1.87e-06 | 963 | 192 | 19 | 28671696 | |
| Pubmed | Celsr1 and Celsr2 exhibit distinct adhesive interactions and contributions to planar cell polarity. | 3.27e-06 | 6 | 192 | 3 | 36712970 | |
| Pubmed | ZFYVE16 MYCBP2 SCAF8 LMNB2 BIRC6 ADD1 CEP170 PHF3 TNRC6A AGFG1 UNK AKAP13 TANC1 QSER1 MGA HCFC1 | 3.56e-06 | 733 | 192 | 16 | 34672954 | |
| Pubmed | NOL4 ZFYVE16 MYCBP2 UBR4 ANKHD1 BIRC6 DST BRCA2 TNRC6A ANKRD17 MGA PROX1 | 4.10e-06 | 418 | 192 | 12 | 34709266 | |
| Pubmed | Foxg1 has an essential role in postnatal development of the dentate gyrus. | 5.70e-06 | 7 | 192 | 3 | 22378868 | |
| Pubmed | 5.70e-06 | 7 | 192 | 3 | 24453220 | ||
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | TCF4 MYO10 SMARCAL1 PHTF2 LMNB2 IDE HRNR TRRAP KIF24 FZD6 SETD5 CTR9 CRLF3 UNK CDK5RAP2 PLA2G6 CSMD1 MED23 FYN MTRF1L AGAP1 | 5.83e-06 | 1242 | 192 | 21 | 30973865 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | AMER1 ABL2 KIAA0319L DPYSL4 CEP192 RGS12 LENG8 CCDC88C PTPN14 NDC80 BRCA2 TNRC6A UNK TANC1 MGA CLEC16A RBFOX2 | 5.84e-06 | 853 | 192 | 17 | 28718761 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | TCF4 SMARCAL1 UBR4 CDK11A POU2F1 LMNB2 HRNR ANKHD1 TRRAP PRDM10 ANKRD17 QSER1 PBX1 MGA HCFC1 FOXG1 FOXD1 | 6.21e-06 | 857 | 192 | 17 | 25609649 |
| Pubmed | FGF signalling generates ventral telencephalic cells independently of SHH. | 7.34e-06 | 23 | 192 | 4 | 16818446 | |
| Pubmed | 7.62e-06 | 49 | 192 | 5 | 21362503 | ||
| Pubmed | AMER1 MAP3K20 CEP192 BIRC6 CEP170 CCDC88C PTPN14 DST CRLF3 TNRC6A UNK TPD52L1 | 7.89e-06 | 446 | 192 | 12 | 24255178 | |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 8.53e-06 | 86 | 192 | 6 | 28327460 | |
| Pubmed | Dual role of brain factor-1 in regulating growth and patterning of the cerebral hemispheres. | 9.09e-06 | 8 | 192 | 3 | 10498272 | |
| Pubmed | 9.09e-06 | 8 | 192 | 3 | 12475935 | ||
| Pubmed | 9.09e-06 | 8 | 192 | 3 | 9886035 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 9.10e-06 | 184 | 192 | 8 | 32908313 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | FLG NOL4 RELN MYCBP2 BTBD17 DPYSL4 LMNB2 HRNR FLG2 EDIL3 TRRAP CEP170 KARS1 DST MED23 PZP CATSPERG PROX1 NPAS2 | 9.84e-06 | 1082 | 192 | 19 | 38697112 |
| Pubmed | Dystroglycan Maintains Inner Limiting Membrane Integrity to Coordinate Retinal Development. | 1.04e-05 | 25 | 192 | 4 | 28760865 | |
| Pubmed | MYCBP2 ANKHD1 TRRAP ADD1 CEP170 PTPN14 PHF3 KMT2A QSER1 MED23 MGA KDM6A HCFC1 | 1.29e-05 | 549 | 192 | 13 | 38280479 | |
| Pubmed | 1.36e-05 | 9 | 192 | 3 | 23840065 | ||
| Pubmed | Early forebrain wiring: genetic dissection using conditional Celsr3 mutant mice. | 1.36e-05 | 9 | 192 | 3 | 18487195 | |
| Pubmed | ABL2 suppresses FLT3-ITD-induced cell proliferation through negative regulation of AKT signaling. | 1.36e-05 | 9 | 192 | 3 | 28086240 | |
| Pubmed | 1.36e-05 | 9 | 192 | 3 | 31919899 | ||
| Pubmed | A family of Acrp30/adiponectin structural and functional paralogs. | 1.36e-05 | 9 | 192 | 3 | 15231994 | |
| Pubmed | 1.51e-05 | 95 | 192 | 6 | 20843830 | ||
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | A2M GPI EML2 LMNB2 IDE ANKHD1 CEP170 CELSR1 KARS1 LOXL1 TNRC6A NAV3 ANKRD17 FYN RBFOX2 | 1.52e-05 | 732 | 192 | 15 | 34732716 |
| Pubmed | A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. | 1.71e-05 | 331 | 192 | 10 | 19490893 | |
| Pubmed | A2M SCAF8 DOCK10 ANKHD1 DST CTR9 KMT2A ANKRD17 AKAP13 TANC1 QSER1 PZP CLEC16A HCFC1 | 1.71e-05 | 650 | 192 | 14 | 38777146 | |
| Pubmed | 1.75e-05 | 332 | 192 | 10 | 37433992 | ||
| Pubmed | 1.78e-05 | 146 | 192 | 7 | 27068509 | ||
| Pubmed | MYCBP2 UBR4 LMNB2 ANKHD1 TRRAP BIRC6 CEP170 KARS1 DST PHF3 MCM3AP KMT2A ANKRD17 HCFC1 | 1.80e-05 | 653 | 192 | 14 | 22586326 | |
| Pubmed | 1.92e-05 | 29 | 192 | 4 | 26620267 | ||
| Pubmed | 1.93e-05 | 10 | 192 | 3 | 26377473 | ||
| Pubmed | 1.93e-05 | 10 | 192 | 3 | 10601035 | ||
| Pubmed | 2.08e-05 | 60 | 192 | 5 | 20682791 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | GRWD1 SMARCAL1 UBR4 TRRAP LENG8 KARS1 MCM3AP KMT2A GREB1 HCFC1 | 2.20e-05 | 341 | 192 | 10 | 32971831 |
| Pubmed | Genetic interplay between the transcription factors Sp8 and Emx2 in the patterning of the forebrain. | 2.20e-05 | 30 | 192 | 4 | 17470284 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 2.21e-05 | 208 | 192 | 8 | 33230847 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | UIMC1 CDK11A CEP192 PTPN14 NDC80 BRCA2 CTR9 MCM3AP TNRC6A AGFG1 UNK TANC1 LRIF1 | 2.63e-05 | 588 | 192 | 13 | 38580884 |
| Pubmed | A forward genetic screen in mice identifies mutants with abnormal cortical patterning. | 2.65e-05 | 11 | 192 | 3 | 23968836 | |
| Pubmed | A dual role for planar cell polarity genes in ciliated cells. | 2.65e-05 | 11 | 192 | 3 | 25024228 | |
| Pubmed | GPI AMER1 KIAA0319L MUC16 CEP192 HRNR FLG2 BIRC6 ADD1 DST TNRC6A CDK5RAP2 MGA CLEC16A AGAP1 | 3.03e-05 | 777 | 192 | 15 | 35844135 | |
| Pubmed | Integrin-mediated dendrite branch maintenance requires Abelson (Abl) family kinases. | 3.03e-05 | 2 | 192 | 2 | 15987940 | |
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 22665498 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 12220663 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 17686996 | ||
| Pubmed | Abl family tyrosine kinases regulate sialylated ganglioside receptors for polyomavirus. | 3.03e-05 | 2 | 192 | 2 | 20181697 | |
| Pubmed | c-Abl and Arg tyrosine kinases regulate lysosomal degradation of the oncoprotein Galectin-3. | 3.03e-05 | 2 | 192 | 2 | 20150913 | |
| Pubmed | Atopic Dermatitis Susceptibility Variants in Filaggrin Hitchhike Hornerin Selective Sweep. | 3.03e-05 | 2 | 192 | 2 | 27678121 | |
| Pubmed | Specificity of MLL1 and TET3 CXXC domains towards naturally occurring cytosine modifications. | 3.03e-05 | 2 | 192 | 2 | 30352306 | |
| Pubmed | Global Regulation of Differential Gene Expression by c-Abl/Arg Oncogenic Kinases. | 3.03e-05 | 2 | 192 | 2 | 28555614 | |
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 7664083 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 19805386 | ||
| Pubmed | BCR-ABL1 mediates up-regulation of Fyn in chronic myelogenous leukemia. | 3.03e-05 | 2 | 192 | 2 | 18180382 | |
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 27859601 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 9889203 | ||
| Pubmed | Abl family nonreceptor tyrosine kinases modulate short-term synaptic plasticity. | 3.03e-05 | 2 | 192 | 2 | 12626632 | |
| Pubmed | Association between restless legs syndrome and CLOCK and NPAS2 gene polymorphisms in schizophrenia. | 3.03e-05 | 2 | 192 | 2 | 24824748 | |
| Pubmed | The Abl family kinases: mechanisms of regulation and signaling. | 3.03e-05 | 2 | 192 | 2 | 12374288 | |
| Pubmed | Defective T cell development and function in the absence of Abelson kinases. | 3.03e-05 | 2 | 192 | 2 | 18025176 | |
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 8454622 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 1692292 | ||
| Pubmed | Inhibition of cell migration by Abl family tyrosine kinases through uncoupling of Crk-CAS complexes. | 3.03e-05 | 2 | 192 | 2 | 11279004 | |
| Pubmed | ANK2 autism mutation targeting giant ankyrin-B promotes axon branching and ectopic connectivity. | 3.03e-05 | 2 | 192 | 2 | 31285321 | |
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 23292348 | ||
| Pubmed | Interdigitated residues within a small region of VP16 interact with Oct-1, HCF, and DNA. | 3.03e-05 | 2 | 192 | 2 | 9199328 | |
| Pubmed | ABL tyrosine kinases: evolution of function, regulation, and specificity. | 3.03e-05 | 2 | 192 | 2 | 20841568 | |
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 28821231 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 11811950 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 8738145 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 9832558 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 21892207 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 14657231 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 21304107 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 7815060 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 33122628 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 24813994 | ||
| Pubmed | Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. | 3.04e-05 | 283 | 192 | 9 | 18854154 | |
| Pubmed | RELN VWF ANK2 MYCBP2 UBR4 KIAA0319L RAP1GAP2 BTBD2 EDIL3 DCAF5 BFSP1 DST CTR9 GLUL NAV3 PLAUR LTBP3 PBX1 KDM6A AGAP1 | 3.20e-05 | 1285 | 192 | 20 | 35914814 | |
| Pubmed | 3.51e-05 | 12 | 192 | 3 | 18783346 | ||
| Pubmed | 3.51e-05 | 12 | 192 | 3 | 23828756 | ||
| Pubmed | Conditional gene expression in the mouse inner ear using Cre-loxP. | 3.51e-05 | 12 | 192 | 3 | 22526732 | |
| Pubmed | Genetic interaction mapping in mammalian cells using CRISPR interference. | 4.11e-05 | 69 | 192 | 5 | 28481362 | |
| Pubmed | 4.21e-05 | 167 | 192 | 7 | 22159717 | ||
| Pubmed | 4.55e-05 | 13 | 192 | 3 | 31070778 | ||
| Pubmed | 4.55e-05 | 13 | 192 | 3 | 26989192 | ||
| Interaction | TOP3B interactions | GPI HSPG2 ABL1 GRWD1 MYCBP2 MYO10 UBR4 L1CAM KAT6A KIAA0319L RAP1GAP2 EML2 CEP192 LMNB2 ANKHD1 TRRAP PRAG1 BIRC6 SLC29A2 CCDC88C CELSR1 HEG1 KARS1 DST CELSR2 NDC80 SETD5 MCM3AP ANKRD17 UNK PLA2G6 AKAP13 TANC1 LTBP3 ULK2 DCAF4 HCFC1 | 3.83e-08 | 1470 | 191 | 37 | int:TOP3B |
| Interaction | POTED interactions | 3.33e-06 | 4 | 191 | 3 | int:POTED | |
| Interaction | KDM1A interactions | CARM1 NOL4 TCF4 ZFYVE16 MYCBP2 UBR4 EML2 ANKHD1 TRRAP CLOCK BIRC6 LENG8 DST BRCA2 NKX2-1 CRLF3 TNRC6A ANKRD17 UNK MED23 MGA FYN FOXG1 PROX1 | 1.01e-05 | 941 | 191 | 24 | int:KDM1A |
| GeneFamily | EF-hand domain containing|S100 fused type protein family | 1.52e-05 | 7 | 139 | 3 | 1350 | |
| GeneFamily | Ankyrin repeat domain containing | 1.08e-04 | 242 | 139 | 9 | 403 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 1.75e-04 | 3 | 139 | 2 | 913 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 1.75e-04 | 3 | 139 | 2 | 1189 | |
| GeneFamily | Endogenous ligands|C1q and TNF related | 3.33e-04 | 18 | 139 | 3 | 1372 | |
| GeneFamily | WD repeat domain containing | 9.61e-04 | 262 | 139 | 8 | 362 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 2.04e-03 | 9 | 139 | 2 | 1234 | |
| GeneFamily | Zinc fingers C2H2-type|Sp transcription factors | 2.04e-03 | 9 | 139 | 2 | 755 | |
| GeneFamily | Zinc fingers CXXC-type | 3.68e-03 | 12 | 139 | 2 | 136 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 4.33e-03 | 13 | 139 | 2 | 685 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SP3 ZFYVE16 MYCBP2 MYO10 SCAF8 KAT6A MAP3K14 TRRAP CLOCK CEP170 HEG1 DST NDC80 BRCA2 PHF3 NAV3 AGFG1 ANKRD17 AKAP13 PLAUR FYN CLEC16A RBFOX2 FOXD1 AGAP1 | 3.91e-09 | 856 | 191 | 25 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | MYCBP2 MYO10 SCAF8 KAT6A TRRAP CLOCK CEP170 HEG1 DST NDC80 PHF3 ANKRD17 FYN CLEC16A RBFOX2 FOXD1 AGAP1 | 6.30e-08 | 466 | 191 | 17 | M13522 |
| Coexpression | GSE4590_SMALL_VS_VPREB_POS_LARGE_PRE_BCELL_DN | 2.95e-07 | 160 | 191 | 10 | M6876 | |
| Coexpression | PEREZ_TP53_TARGETS | PLIN4 FLG COL15A1 MYO10 INPP5D MAP3K14 EML6 DPYSL4 RIPOR3 TYSND1 KCNK7 ARHGAP6 HEG1 HOXC6 CELSR2 PTPRJ STRADA LOXL1 LTBP3 GREB1 MED23 FYN KDM6A DOP1A AGAP1 GABRA4 | 7.02e-07 | 1201 | 191 | 26 | M4391 |
| Coexpression | NABA_MATRISOME | A2M FLG HSPG2 RELN FLT3LG VWF COL15A1 COL16A1 MUC16 HRNR FLG2 EDIL3 FREM1 EYS MUC17 LOXL1 CRLF3 C1QTNF3 C1QTNF2 LTBP3 C1QTNF7 PZP HCFC1 | 1.82e-06 | 1026 | 191 | 23 | M5889 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | FLG SP3 ABL1 KAT6A CEP170 HEG1 DST PHF3 NAV3 FYN DOP1A NPAS2 | 2.27e-06 | 300 | 191 | 12 | M8702 |
| Coexpression | HAN_SATB1_TARGETS_DN | UIMC1 TCF4 ABL1 GRWD1 MYO10 KAT6A CDK11A EML2 DST QSER1 CD96 FOXG1 NPAS2 | 5.95e-06 | 388 | 191 | 13 | M15491 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | ZFYVE16 MYO10 ZNF175 MAP3K20 CLOCK ATP10A DCAF5 DST RNF6 PTPRJ GAB4 AGFG1 ADGRE5 TANC1 C1QTNF7 MED23 FYN ULK2 KDM6A GABRA4 | 8.40e-06 | 888 | 191 | 20 | MM1018 |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 1.17e-05 | 145 | 191 | 8 | M1810 | |
| Coexpression | CUI_DEVELOPING_HEART_CORONARY_VASCULAR_ENDOTHELIAL_CELL | 1.18e-05 | 41 | 191 | 5 | M39320 | |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_UP | MYCBP2 RAP1GAP2 DPYSL4 POU2F1 IDE KCNK7 CELSR2 DCLRE1C C1QTNF3 | 1.58e-05 | 198 | 191 | 9 | M3449 |
| Coexpression | NABA_MATRISOME | A2M HSPG2 RELN FLT3LG VWF COL15A1 COL16A1 MUC16 HRNR FLG2 EDIL3 FREM1 MUC17 LOXL1 CRLF3 C1QTNF3 C1QTNF2 LTBP3 C1QTNF7 PZP HCFC1 | 1.60e-05 | 1008 | 191 | 21 | MM17056 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | ZFYVE16 MYO10 ZNF175 MAP3K20 CLOCK ATP10A DCAF5 DST RNF6 PTPRJ AGFG1 ADGRE5 TANC1 C1QTNF7 MED23 FYN ULK2 KDM6A GABRA4 | 1.69e-05 | 854 | 191 | 19 | M1533 |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 2.60e-05 | 162 | 191 | 8 | M45037 | |
| Coexpression | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP | 2.61e-05 | 211 | 191 | 9 | M12225 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SP3 FLT3LG MYCBP2 SCAF8 INPP5D UBR4 KAT6A DOCK10 PHTF2 BIRC6 DCAF5 ARID5A ADD1 IFNAR2 CCDC88C HEG1 PTPRJ SETD5 PHF3 CRLF3 AGFG1 KMT2A AKAP13 ADGRE5 FYN CD96 | 3.34e-05 | 1492 | 191 | 26 | M40023 |
| Coexpression | LI_ESTROGENE_EARLY_E2_RESPONSE_UP | 4.57e-05 | 88 | 191 | 6 | M48213 | |
| Coexpression | GAL_LEUKEMIC_STEM_CELL_UP | 4.85e-05 | 130 | 191 | 7 | M17428 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | TCF4 RELN ABL1 VWF L1CAM PHTF2 ARHGAP6 DST GLUL KMT2A ADGRE5 LTBP3 PBX1 FYN INVS TPD52L1 | 8.28e-05 | 721 | 191 | 16 | M1999 |
| Coexpression | SANSOM_APC_TARGETS | ATG9B DCAF4L2 RGS12 FZD6 NDC80 CDK5RAP2 AKAP13 DCAF4 TPD52L1 | 8.29e-05 | 245 | 191 | 9 | MM735 |
| Coexpression | GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_IFNAR_KO_UP | 9.31e-05 | 194 | 191 | 8 | M9980 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 1.11e-04 | 199 | 191 | 8 | M5893 | |
| Coexpression | GSE20715_WT_VS_TLR4_KO_LUNG_DN | 1.11e-04 | 199 | 191 | 8 | M4350 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP | 1.15e-04 | 200 | 191 | 8 | M8030 | |
| Coexpression | GSE2826_WT_VS_BTK_KO_BCELL_UP | 1.15e-04 | 200 | 191 | 8 | M4898 | |
| Coexpression | GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_DN | 1.15e-04 | 200 | 191 | 8 | M7150 | |
| Coexpression | GSE5679_RARA_AGONIST_AM580_VS_AM580_AND_ROSIGLITAZONE_TREATED_DC_DN | 1.15e-04 | 200 | 191 | 8 | M6570 | |
| Coexpression | ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN | 1.16e-04 | 104 | 191 | 6 | M6189 | |
| Coexpression | SANSOM_APC_TARGETS | 1.56e-04 | 209 | 191 | 8 | M1755 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | SP3 AMER1 ABL2 COL16A1 BIRC6 C4orf54 ADD1 HEG1 HOXC6 TNRC6A GLUL PKHD1 C2 GNB4 C1QTNF3 C1QTNF2 LTBP3 C1QTNF7 PZP MGA KDM6A AGAP1 GABRA4 | 7.21e-07 | 797 | 189 | 23 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | RELN COL15A1 MYCBP2 MYO10 COX18 IDE BIRC6 HOXB5 CELSR1 PTPN14 DST CELSR2 PHF3 PKHD1 AKAP13 GNB4 C1QTNF2 GREB1 MGA RBFOX2 FOXD1 | 8.88e-06 | 795 | 189 | 21 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | SP3 AMER1 ABL2 MYO10 NEXMIF ANKHD1 BIRC6 ADD1 HOXC6 TNRC6A ANKRD17 MAEL GNB4 C1QTNF7 TAF4B MGA FYN KDM6A AGAP1 TPD52L1 GABRA4 | 1.09e-05 | 806 | 189 | 21 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.27e-05 | 58 | 189 | 6 | gudmap_kidney_P0_CapMes_Crym_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | SP3 AMER1 ABL2 COL16A1 BIRC6 ADD1 HEG1 HOXC6 TNRC6A GLUL PKHD1 C2 GNB4 C1QTNF3 C1QTNF7 MGA KDM6A RBFOX2 AGAP1 GABRA4 | 3.16e-05 | 799 | 189 | 20 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_500 | SP3 ABL2 ADD1 HEG1 GLUL PKHD1 C2 C1QTNF3 C1QTNF2 C1QTNF7 PZP MGA GABRA4 | 5.67e-05 | 395 | 189 | 13 | gudmap_developingGonad_P2_epididymis_500 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000 | ANK2 SCAF8 EDIL3 CEP170 GNB4 C1QTNF3 C1QTNF2 LTBP3 PBX1 ULK2 FOXD1 | 5.73e-05 | 288 | 189 | 11 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | SP3 ABL2 MYO10 NEXMIF BIRC6 ADD1 BFSP1 HEG1 PTPRJ MAEL GNB4 GREB1 C1QTNF7 TAF4B MGA FYN KDM6A AGAP1 GABRA4 | 6.10e-05 | 770 | 189 | 19 | gudmap_developingGonad_P2_ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000 | TCF4 RELN SCAF8 MAP3K14 EML6 POU2F1 CEP192 PRAG1 BIRC6 KIF24 CCDC88C PTPN14 DST KIAA1549L CELSR2 NKX2-1 PHF3 SLAIN1 GREB1 HCFC1 MMUT FOXD1 | 7.89e-05 | 994 | 189 | 22 | Facebase_RNAseq_e8.5_Floor Plate_1000 |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_500 | 1.05e-04 | 28 | 189 | 4 | gudmap_kidney_P2_CapMes_Crym_k4_500 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 1.59e-04 | 31 | 189 | 4 | gudmap_kidney_P1_CapMes_Crym_k3_500 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 1.59e-04 | 31 | 189 | 4 | gudmap_kidney_P0_CapMes_Crym_k3_500 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_k-means-cluster#1_top-relative-expression-ranked_200 | 1.86e-04 | 13 | 189 | 3 | gudmap_kidney_P2_CapMes_Crym_k1_200 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.03e-08 | 190 | 191 | 10 | 1519f34d31fe0817184c5865a0bc9f0cb479b1a4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-08 | 196 | 191 | 10 | ab7be3858deabbd1fc44e8b9da8ff49a50bf1fb1 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-07 | 189 | 191 | 9 | 979b7fa947538aa7ca4a219263da2575869a2caa | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.40e-07 | 190 | 191 | 9 | 3b8d1e66ae68c1eee64095e75195d76d97e24026 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.40e-07 | 190 | 191 | 9 | f50b9814a1beac67dc042a8c27dfd085ceeda3a6 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.40e-07 | 190 | 191 | 9 | a22a510b4a257eb0eaf09c7ae7978d3d2f07a58c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.40e-07 | 190 | 191 | 9 | dc655e4782aab274f0c9b6e36a5ce315e3a1a4b9 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.40e-07 | 190 | 191 | 9 | 57c136bf6d7feafb4a220877bed0cc8fdf314db2 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-07 | 192 | 191 | 9 | c0e59e642b42c055cf73d029cf54d07d9b719359 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.54e-07 | 192 | 191 | 9 | f6ec683b2133b3095a1fcc06ca8605cf38f774b5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.54e-07 | 192 | 191 | 9 | 690b3d17c481159bc96b8bc7f6a66b51343ee858 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-07 | 193 | 191 | 9 | 52e918884877b6659cdca0496390e440f73694a9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.68e-07 | 194 | 191 | 9 | 52aebb0b563e2c2058e7f0554ae870e47692b163 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.68e-07 | 194 | 191 | 9 | 5d0b0d8e96f0e0297a4dba70a05d87081a4eb323 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.68e-07 | 194 | 191 | 9 | bd06e2b8d8c06cddf2e4f58849b86e09013acae1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.68e-07 | 194 | 191 | 9 | 6ac759828c41ffa974ee82842162caa959351dd1 | |
| ToppCell | IIH-mono3-|IIH / Condition, Cell_class and T cell subcluster | 1.75e-07 | 195 | 191 | 9 | 28a858b04a7b413916c07a8d880f5ea02e985461 | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.75e-07 | 195 | 191 | 9 | 9d649ac7d2af313481069c95349efc0c68449e2b | |
| ToppCell | IIH-mono3|IIH / Condition, Cell_class and T cell subcluster | 1.75e-07 | 195 | 191 | 9 | c6dd5af582d257be64b718e30f60220c1bf1738a | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+VCAM1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.83e-07 | 196 | 191 | 9 | ac2c4a325efa8497a755cd31fb6a9d94d8e3bf42 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | A2M COL15A1 COL16A1 EDIL3 KIAA1549L LOXL1 TANC1 RBFOX2 FOXD1 | 1.91e-07 | 197 | 191 | 9 | c165c6fd12dc649b39e920d8528e2eb65c61956b |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 1.99e-07 | 198 | 191 | 9 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | HSPG2 COL16A1 ANK2 EDIL3 PTPN14 C1QTNF3 C1QTNF2 RBFOX2 AGAP1 | 1.99e-07 | 198 | 191 | 9 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 1.99e-07 | 198 | 191 | 9 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.17e-07 | 200 | 191 | 9 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.17e-07 | 200 | 191 | 9 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.39e-07 | 163 | 191 | 8 | 8d17f44faf0549fe71a9a45f811f50d767275414 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.65e-07 | 164 | 191 | 8 | 08819970174a3eb4eee8e1e675075828665b845e | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.09e-07 | 169 | 191 | 8 | 665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.09e-07 | 169 | 191 | 8 | 6614c9851537e4c21b1e45ff0cc3bad07ef9d034 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.24e-06 | 182 | 191 | 8 | 0346f81bbb1f309f3e9d063b20547d548d09472c | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.35e-06 | 184 | 191 | 8 | 01257e5c12e38b849fd3d9496c43ded666249ba5 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-06 | 184 | 191 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-06 | 184 | 191 | 8 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-06 | 184 | 191 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.35e-06 | 184 | 191 | 8 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-06 | 184 | 191 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-06 | 185 | 191 | 8 | 3a4ae836e882e8d29eb0a2dfab5677f10f2d365f | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.40e-06 | 185 | 191 | 8 | 602536a3308a848f106adcb0a83530997440c8f4 | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-06 | 185 | 191 | 8 | 224f0b022c21dd40bf1f7503f00b3107ef958975 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.46e-06 | 186 | 191 | 8 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.58e-06 | 188 | 191 | 8 | 0501a8aa850bd2e347020abd1cac4d8075738189 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.58e-06 | 188 | 191 | 8 | 3cfba3addcc9058f4ec31ad96261f79988f551a0 | |
| ToppCell | COVID-19-kidney-CD-PC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.58e-06 | 188 | 191 | 8 | 8f9996c3f3b27efaaae8960a66af77412de9c7ef | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.64e-06 | 189 | 191 | 8 | db09d591b885ce2bc9e353f08b6694e2192582e1 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.64e-06 | 189 | 191 | 8 | f0aaf2994d319a39877d2845eaab9f166adead4e | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-06 | 189 | 191 | 8 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_activate-7|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.68e-06 | 132 | 191 | 7 | c07842a4b514f1e950c8af303f3b6b4275906e6a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.71e-06 | 190 | 191 | 8 | 56cc761e50fddfb5366391518b4d8e16589b6b42 | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.71e-06 | 190 | 191 | 8 | 2a8de1cf27a9ebc3825cf9e7a489ecd064dfc7f9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.71e-06 | 190 | 191 | 8 | 25d4b591f75c26e404a34c42f1742d580af6598d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.78e-06 | 191 | 191 | 8 | fa50a3c7ff86e1ee07100da1ace0b0fa1b0ab26b | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.78e-06 | 191 | 191 | 8 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-06 | 192 | 191 | 8 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-06 | 192 | 191 | 8 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-06 | 192 | 191 | 8 | 29bee88b45e23f16543ffc7cc361bc5da5d16a2b | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-06 | 192 | 191 | 8 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.85e-06 | 192 | 191 | 8 | 342842378c20267c5044bdd622515e8b9f895623 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.85e-06 | 192 | 191 | 8 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-06 | 192 | 191 | 8 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.85e-06 | 192 | 191 | 8 | bd3fa6c8fcb618db64d11f25cabaf08608957c35 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.85e-06 | 192 | 191 | 8 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-06 | 192 | 191 | 8 | cdc652dbfabe41b324fd85c1ed933d29fb73a49f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.92e-06 | 193 | 191 | 8 | 294cb5b580bb83fe0eb04f112d5507aac35d4d44 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-06 | 193 | 191 | 8 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | COVID-19-kidney-CD-PC|kidney / Disease (COVID-19 only), tissue and cell type | 1.92e-06 | 193 | 191 | 8 | 738689d009e4b118d7ce3171a207294b95cbe78b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.92e-06 | 193 | 191 | 8 | 3d3c45d5ff6f3396a1990615aae9fe176e799994 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-06 | 194 | 191 | 8 | a52c5906fce43c2f72cf7e463a3d15cde06431f6 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.00e-06 | 194 | 191 | 8 | b30379f8dc41c86c746af9930541fbb4819d8fa0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-06 | 194 | 191 | 8 | e55dc30e200c9f576804acb642175eb4fa9146b5 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-06 | 195 | 191 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 2.08e-06 | 195 | 191 | 8 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.08e-06 | 195 | 191 | 8 | 98ca9f3aa36211dde1e6f7f3817b9418c95e583e | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.16e-06 | 196 | 191 | 8 | ae46d4b00be92e64e46252dcc156161b171eded4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-06 | 196 | 191 | 8 | 023312af38f816a44b407e0daa32590d953caf99 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.16e-06 | 196 | 191 | 8 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.24e-06 | 197 | 191 | 8 | 86a02fd7b4762b3278e5e60b5483b5fc1206e597 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.24e-06 | 197 | 191 | 8 | 7a1a3839b2c965136663241b0d4e96c64cfb656a | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-blood_vessel_EC|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.33e-06 | 198 | 191 | 8 | 5b86dc00acf8ac2ede008f5d79c09996485bf250 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 2.33e-06 | 198 | 191 | 8 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-06 | 198 | 191 | 8 | fa84bf8533d1b91d2c2bcf06b710670605072b89 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-06 | 198 | 191 | 8 | 0a172c6d997c7cfbad34b56e80121bd104dee67d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-06 | 198 | 191 | 8 | 07701c73137947ed4a27e225975329235bbb8734 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.41e-06 | 199 | 191 | 8 | b15304d3d3f6c254969b54a61bee3d9f368840b2 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_CTL|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.41e-06 | 199 | 191 | 8 | eb188b0b457136b6ee485d3b3052baa30d9c0002 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 2.41e-06 | 199 | 191 | 8 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.51e-06 | 200 | 191 | 8 | 082e718c1da3f4fdd33a001d15ad3ddb2be985c7 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.51e-06 | 200 | 191 | 8 | d0167f96314be78b6d867bbcc6e4396071d931b8 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 2.51e-06 | 200 | 191 | 8 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.51e-06 | 200 | 191 | 8 | e90155498397524b812c46f2412320230b445bb6 | |
| ToppCell | Neuronal-Inhibitory-iA|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.51e-06 | 200 | 191 | 8 | 5ef4a3dc18a44292184a59ced916183c0699b01e | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.51e-06 | 200 | 191 | 8 | 731e55070a7ff315091855bd88cda30e5a7e1a98 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-LCP2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.51e-06 | 200 | 191 | 8 | 7345cc7dc24b9174541a3e68ecac8c4c092be400 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.51e-06 | 200 | 191 | 8 | d416a7be1a4e6232fb58a9687774da24821f1fdd | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SCUBE3--L2-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.51e-06 | 200 | 191 | 8 | d841dbe2297c3bf62f49bae5921662cd6a47e5c2 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SCUBE3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.51e-06 | 200 | 191 | 8 | 2441a36d363b799a4692aa697f969cda056c2d60 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-LCP2--L1-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.51e-06 | 200 | 191 | 8 | f268cb1bb047e88913a828614b0a77871f5f8814 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_2(LAMP5)-LCP2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.51e-06 | 200 | 191 | 8 | 5ff9ac97ef970b3b74ebb07f62a0a1f4176a10b4 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.51e-06 | 200 | 191 | 8 | 862db57d043bdf3cb059fbfc8b29bc1eafdf64ec | |
| ToppCell | 390C-Endothelial_cells-Endothelial-A_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.51e-06 | 200 | 191 | 8 | 50b8788494b744e0f0ec8c4d67a1c90ae09dca65 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | SCAF8 SMARCAL1 DOCK10 LMNB2 CLOCK PRDM10 NDC80 LOXL1 NAV3 LRIF1 | 2.39e-06 | 179 | 187 | 10 | 2105_DN |
| Drug | Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; PC3; HT_HG-U133A | 4.46e-06 | 192 | 187 | 10 | 5058_DN | |
| Drug | Xamoterol hemifumarate [73210-73-8]; Up 200; 5uM; MCF7; HT_HG-U133A | COL16A1 PHTF2 ARID5A SLC9A5 MCM3AP SCNN1B PLAUR ULK2 HCFC1 FOXG1 | 5.12e-06 | 195 | 187 | 10 | 3401_UP |
| Drug | Vincamine [1617-90-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 5.61e-06 | 197 | 187 | 10 | 3865_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 1.24e-05 | 171 | 187 | 9 | 7535_DN | |
| Disease | cortical thickness | A2M HSPG2 TCF4 RELN NYAP2 MYCBP2 SMARCAL1 DPYSL4 EML2 CLOCK CELSR1 SETD5 TNRC6A PKHD1 NAV3 KMT2A CDK5RAP2 MAEL QSER1 ULK2 AGAP1 | 7.37e-06 | 1113 | 185 | 21 | EFO_0004840 |
| Disease | Neurodevelopmental Disorders | 2.72e-05 | 93 | 185 | 6 | C1535926 | |
| Disease | waist-hip ratio | PLIN4 NYAP2 COL15A1 MYCBP2 MAP3K14 PHTF2 CEP192 CLOCK BIRC6 HOXC6 CASTOR1 LOXL1 TNRC6A NAV3 C1QTNF3 LTBP3 C1QTNF7 PBX1 CLEC16A PROX1 NPAS2 | 3.10e-05 | 1226 | 185 | 21 | EFO_0004343 |
| Disease | free cholesterol to total lipids in very large VLDL percentage | 3.49e-05 | 59 | 185 | 5 | EFO_0022289 | |
| Disease | bitter alcoholic beverage consumption measurement | 1.99e-04 | 133 | 185 | 6 | EFO_0010092 | |
| Disease | bipolar disorder (is_marker_for) | 2.18e-04 | 19 | 185 | 3 | DOID:3312 (is_marker_for) | |
| Disease | hydrocephalus (implicated_via_orthology) | 2.18e-04 | 19 | 185 | 3 | DOID:10908 (implicated_via_orthology) | |
| Disease | Medulloblastoma | 2.75e-04 | 50 | 185 | 4 | C0025149 | |
| Disease | Precursor B-cell lymphoblastic leukemia | 2.97e-04 | 21 | 185 | 3 | C1292769 | |
| Disease | cholesterol to total lipids in small VLDL percentage | 2.97e-04 | 51 | 185 | 4 | EFO_0022242 | |
| Disease | triglycerides to total lipids in very large VLDL percentage | 3.45e-04 | 53 | 185 | 4 | EFO_0022340 | |
| Disease | cholesterol to total lipids in very large VLDL percentage | 3.70e-04 | 54 | 185 | 4 | EFO_0022244 | |
| Disease | alcohol use disorder measurement, alcohol consumption measurement | 3.71e-04 | 97 | 185 | 5 | EFO_0007878, EFO_0009458 | |
| Disease | hepatocellular adenoma (biomarker_via_orthology) | 3.86e-04 | 5 | 185 | 2 | DOID:0050868 (biomarker_via_orthology) | |
| Disease | intraocular pressure measurement | TCF4 RELN COL16A1 CDK11A PTPRJ PKHD1 KMT2A AKAP13 LTBP3 FYN NPAS2 | 3.94e-04 | 509 | 185 | 11 | EFO_0004695 |
| Disease | HOMA-B | 3.97e-04 | 55 | 185 | 4 | EFO_0004469 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 4.56e-04 | 57 | 185 | 4 | EFO_0022284 | |
| Disease | pyroglutamine measurement | 4.87e-04 | 58 | 185 | 4 | EFO_0005408 | |
| Disease | severe acute respiratory syndrome, COVID-19 | RELN FRMPD4 INPP5D RAP1GAP2 EDIL3 ARHGAP6 EYS LTBP3 CSMD1 PBX1 | 5.54e-04 | 447 | 185 | 10 | EFO_0000694, MONDO_0100096 |
| Disease | Antiglaucoma preparations and miotics use measurement | 5.67e-04 | 26 | 185 | 3 | EFO_0009944 | |
| Disease | hydrocephalus (is_implicated_in) | 5.77e-04 | 6 | 185 | 2 | DOID:10908 (is_implicated_in) | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 6.68e-04 | 63 | 185 | 4 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 6.68e-04 | 63 | 185 | 4 | EFO_0022239 | |
| Disease | cholesteryl esters to total lipids in medium VLDL percentage | 7.09e-04 | 64 | 185 | 4 | EFO_0022253 | |
| Disease | respiratory failure, COVID-19 | 7.86e-04 | 29 | 185 | 3 | EFO_0009686, MONDO_0100096 | |
| Disease | LDL cholesterol change measurement | 8.04e-04 | 7 | 185 | 2 | EFO_0007804 | |
| Disease | remission | 8.04e-04 | 7 | 185 | 2 | EFO_0009785 | |
| Disease | cholesterol to total lipids in very small VLDL percentage | 8.42e-04 | 67 | 185 | 4 | EFO_0022245 | |
| Disease | diabetes mellitus | 8.91e-04 | 68 | 185 | 4 | EFO_0000400 | |
| Disease | lymphocyte count | TCF4 NYAP2 ABL1 IAPP EML6 DOCK10 RAP1GAP2 RIPOR3 PTPRJ DCLRE1C CRLF3 MCM3AP PLA2G6 ADGRE5 PLAUR LTBP3 C1QTNF7 PBX1 CLEC16A AGAP1 | 9.18e-04 | 1464 | 185 | 20 | EFO_0004587 |
| Disease | attempted suicide | 9.33e-04 | 178 | 185 | 6 | EFO_0004321 | |
| Disease | Cornelia De Lange Syndrome | 1.07e-03 | 8 | 185 | 2 | C0270972 | |
| Disease | mood instability measurement | 1.30e-03 | 128 | 185 | 5 | EFO_0008475 | |
| Disease | Autistic Disorder | 1.35e-03 | 261 | 185 | 7 | C0004352 | |
| Disease | level of Sphingomyelin (d36:1) in blood serum | 1.37e-03 | 9 | 185 | 2 | OBA_2045178 | |
| Disease | triglyceride change measurement, response to exercise | 1.37e-03 | 9 | 185 | 2 | EFO_0007681, EFO_0007768 | |
| Disease | cerebrospinal fluid clusterin measurement | 1.37e-03 | 35 | 185 | 3 | EFO_0007657 | |
| Disease | age at menarche | UIMC1 NOL4 TCF4 MYO10 WDR25 DST NKX2-1 TNRC6A GREB1 CSMD1 AGAP1 | 1.39e-03 | 594 | 185 | 11 | EFO_0004703 |
| Disease | Schizophrenia | TCF4 RELN IDE TRRAP CLOCK RGS12 PANK2 GLUL KMT2A PLA2G6 CSMD1 FYN GABRA4 NPAS2 | 1.42e-03 | 883 | 185 | 14 | C0036341 |
| Disease | Lung diseases | 1.49e-03 | 78 | 185 | 4 | C0024115 | |
| Disease | Burkitt Lymphoma | 1.49e-03 | 36 | 185 | 3 | C0006413 | |
| Disease | Alzheimer's disease (is_implicated_in) | 1.49e-03 | 132 | 185 | 5 | DOID:10652 (is_implicated_in) | |
| Disease | macrophage colony stimulating factor measurement | 1.61e-03 | 37 | 185 | 3 | EFO_0008217 | |
| Disease | cerebral palsy (implicated_via_orthology) | 1.70e-03 | 10 | 185 | 2 | DOID:1969 (implicated_via_orthology) | |
| Disease | adult onset asthma, body mass index | 1.70e-03 | 10 | 185 | 2 | EFO_0004340, EFO_1002011 | |
| Disease | glucagon-like peptide-1 measurement | 1.70e-03 | 10 | 185 | 2 | EFO_0008465 | |
| Disease | psoriasis | 1.74e-03 | 273 | 185 | 7 | EFO_0000676 | |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 1.76e-03 | 137 | 185 | 5 | EFO_0004611, EFO_0008591 | |
| Disease | cortical surface area measurement | TCF4 RELN NYAP2 MYCBP2 MAP3K14 DOCK10 EML2 CCDC88C CELSR1 TNRC6A PKHD1 NAV3 AGFG1 MAEL QSER1 MED23 FOXG1 AGAP1 | 2.08e-03 | 1345 | 185 | 18 | EFO_0010736 |
| Disease | sleep duration | 2.12e-03 | 362 | 185 | 8 | EFO_0005271 | |
| Disease | autistic disorder (is_marker_for) | 2.48e-03 | 12 | 185 | 2 | DOID:12849 (is_marker_for) | |
| Disease | Childhood Medulloblastoma | 2.49e-03 | 43 | 185 | 3 | C0278510 | |
| Disease | Melanotic medulloblastoma | 2.49e-03 | 43 | 185 | 3 | C1275668 | |
| Disease | Medullomyoblastoma | 2.49e-03 | 43 | 185 | 3 | C0205833 | |
| Disease | Desmoplastic Medulloblastoma | 2.49e-03 | 43 | 185 | 3 | C0751291 | |
| Disease | Adult Medulloblastoma | 2.49e-03 | 43 | 185 | 3 | C0278876 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 2.49e-03 | 43 | 185 | 3 | EFO_0022290 | |
| Disease | Seizures | 2.60e-03 | 218 | 185 | 6 | C0036572 | |
| Disease | schizophrenia (is_marker_for) | 2.66e-03 | 44 | 185 | 3 | DOID:5419 (is_marker_for) | |
| Disease | age at diagnosis, osteonecrosis | 2.66e-03 | 44 | 185 | 3 | EFO_0004259, EFO_0004918 | |
| Disease | cholesterol to total lipids in large VLDL percentage | 2.84e-03 | 45 | 185 | 3 | EFO_0022236 | |
| Disease | potassium measurement | 2.84e-03 | 45 | 185 | 3 | EFO_0009283 | |
| Disease | squamous cell carcinoma, multiple keratinocyte carcinoma susceptibility measurement, basal cell carcinoma | 2.91e-03 | 13 | 185 | 2 | EFO_0000707, EFO_0004193, EFO_0007932 | |
| Disease | Neurodegeneration with brain iron accumulation | 2.91e-03 | 13 | 185 | 2 | cv:C2931845 | |
| Disease | platelet component distribution width | NYAP2 VWF DOCK10 RIPOR3 BTBD2 C4orf54 DCAF5 CRLF3 PLA2G6 AKAP13 ADGRE5 NPAS2 | 3.02e-03 | 755 | 185 | 12 | EFO_0007984 |
| Disease | age at menopause | 3.07e-03 | 302 | 185 | 7 | EFO_0004704 | |
| Disease | neuroimaging measurement | TCF4 RELN DPYSL4 EML2 KCNK7 CCDC88C CELSR1 CASTOR1 TNRC6A PKHD1 NAV3 MAEL QSER1 FOXG1 AGAP1 | 3.14e-03 | 1069 | 185 | 15 | EFO_0004346 |
| Disease | colorectal cancer (is_marker_for) | 3.18e-03 | 157 | 185 | 5 | DOID:9256 (is_marker_for) | |
| Disease | atrial fibrillation (is_implicated_in) | 3.39e-03 | 14 | 185 | 2 | DOID:0060224 (is_implicated_in) | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 3.39e-03 | 14 | 185 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | biological sex | 3.39e-03 | 230 | 185 | 6 | PATO_0000047 | |
| Disease | Acute Confusional Senile Dementia | 3.54e-03 | 99 | 185 | 4 | C0546126 | |
| Disease | Alzheimer's Disease, Focal Onset | 3.54e-03 | 99 | 185 | 4 | C0750900 | |
| Disease | Alzheimer Disease, Early Onset | 3.54e-03 | 99 | 185 | 4 | C0750901 | |
| Disease | Presenile dementia | 3.54e-03 | 99 | 185 | 4 | C0011265 | |
| Disease | Alzheimer Disease, Late Onset | 3.54e-03 | 99 | 185 | 4 | C0494463 | |
| Disease | Familial Alzheimer Disease (FAD) | 3.67e-03 | 100 | 185 | 4 | C0276496 | |
| Disease | Adenoid Cystic Carcinoma | 3.67e-03 | 100 | 185 | 4 | C0010606 | |
| Disease | Alzheimer's Disease | 3.81e-03 | 101 | 185 | 4 | C0002395 | |
| Disease | triglycerides to total lipids in medium LDL percentage | 3.83e-03 | 50 | 185 | 3 | EFO_0022334 | |
| Disease | response to statin, LDL cholesterol change measurement | 3.89e-03 | 15 | 185 | 2 | EFO_0007804, GO_0036273 | |
| Disease | hepcidin:transferrin saturation ratio | 3.89e-03 | 15 | 185 | 2 | EFO_0007902 | |
| Disease | chronotype measurement | NOL4 TCF4 RELN ANK2 MYCBP2 MAP3K20 PRAG1 BIRC6 PKHD1 NAV3 CSMD1 MTRF1L NPAS2 | 3.89e-03 | 882 | 185 | 13 | EFO_0008328 |
| Disease | triglycerides to total lipids in large LDL percentage | 4.05e-03 | 51 | 185 | 3 | EFO_0022331 | |
| Disease | creatinine measurement | PLIN4 TCF4 NYAP2 SCAF8 MAP3K14 PHTF2 BIRC6 RGS12 PTPN14 CELSR2 PTPRJ PKHD1 PLA2G6 MED23 | 4.18e-03 | 995 | 185 | 14 | EFO_0004518 |
| Disease | obesity | 4.26e-03 | 241 | 185 | 6 | EFO_0001073 | |
| Disease | cutaneous Leishmaniasis | 4.43e-03 | 16 | 185 | 2 | EFO_0005046 | |
| Disease | Seasonal Affective Disorder | 4.43e-03 | 16 | 185 | 2 | C0085159 | |
| Disease | level of Sterol ester (27:1/18:1) in blood serum | 4.43e-03 | 16 | 185 | 2 | OBA_2045195 | |
| Disease | age-related hearing impairment | 4.50e-03 | 324 | 185 | 7 | EFO_0005782 | |
| Disease | cholesteryl esters to total lipids in very large VLDL percentage | 4.51e-03 | 53 | 185 | 3 | EFO_0022258 | |
| Disease | serum selenium measurement | 4.51e-03 | 53 | 185 | 3 | EFO_0005266 | |
| Disease | mitochondrial DNA measurement | 4.80e-03 | 328 | 185 | 7 | EFO_0006312 | |
| Disease | Liver carcinoma | 4.89e-03 | 507 | 185 | 9 | C2239176 | |
| Disease | Colorectal Carcinoma | ANK2 EML2 LMNB2 MCM3AP NPAP1 PKHD1 SCNN1B GNB4 GPNMB PZP KDM6A | 4.95e-03 | 702 | 185 | 11 | C0009402 |
| Disease | peptide measurement | 4.99e-03 | 109 | 185 | 4 | EFO_0010520 | |
| Disease | Eye Abnormalities | 5.00e-03 | 17 | 185 | 2 | C0015393 | |
| Disease | triacylglycerol 48:1 measurement | 5.00e-03 | 17 | 185 | 2 | EFO_0010404 | |
| Disease | mean platelet volume | VWF EML6 DOCK10 BTBD2 DCAF5 RGS12 PTPRJ CTR9 CRLF3 TNRC6A ADGRE5 PBX1 CATSPERG ULK2 | 5.18e-03 | 1020 | 185 | 14 | EFO_0004584 |
| Disease | cholesterol to total lipids in large LDL percentage | 5.27e-03 | 56 | 185 | 3 | EFO_0022235 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NSGHSTSKGDRVAQS | 791 | Q5SW79 | |
| GHSFRTQSELGTAFQ | 776 | Q6ZRH7 | |
| TNVVTGHRQSFGTNS | 311 | Q8WV16 | |
| TEQQGLASGSSVSFV | 216 | Q03989 | |
| LSTGAAHSEGFSVQE | 191 | Q8N8Q8 | |
| SAVHISQTSNGGGSL | 261 | Q9UPQ3 | |
| SGSHNLGAQQTSARS | 3726 | Q9NR09 | |
| LSGNHTEQSNFTSRS | 2391 | Q96PZ7 | |
| TGNFSSVASLQHADG | 686 | P42684 | |
| VATGSFHSGAVTDNG | 96 | Q96Q42 | |
| VSSHSGAAVQAAGVT | 81 | Q8WTX7 | |
| SVVGAQHLVSSTGAS | 561 | Q07092 | |
| GDNTGLFVSTNHTVN | 286 | Q14956 | |
| STSFQTQLGPSGHDA | 336 | A6NE02 | |
| SEFTSTTSGTGHNQT | 811 | P48960 | |
| SNIGTAGASDVHVTS | 511 | Q12802 | |
| SGTSQISHRGITSAF | 671 | Q5JTC6 | |
| NESSQFLSVSAEGGH | 1211 | Q5JWR5 | |
| ATQHTGTLFGNDVRT | 2141 | Q9NYQ6 | |
| AHESTQRGFGLSATQ | 2086 | Q9HCU4 | |
| DSSRHSQVGQGQSSG | 596 | P20930 | |
| GTRHTQNSSSGQAAS | 681 | P20930 | |
| GQAASSHEQARSSAG | 691 | P20930 | |
| ETSSGGQAASSHEQA | 1011 | P20930 | |
| SSRHSQVGQEQSSGS | 1246 | P20930 | |
| RHAETSSGGQAASSQ | 1656 | P20930 | |
| SGGQAASSHEQARSS | 2311 | P20930 | |
| TQTSSGGQAASSHEQ | 2631 | P20930 | |
| GGQAASSHEQARSSA | 2636 | P20930 | |
| DSDTQSVSAHGQAGS | 2701 | P20930 | |
| QTSSGGQAASSHEQA | 2956 | P20930 | |
| GQAASSHEQARSSAG | 2961 | P20930 | |
| TSSGGQAASSHEQAR | 3281 | P20930 | |
| TQADSSRHSQSGQGQ | 3511 | P20930 | |
| SSGGQAASSHEQARS | 3606 | P20930 | |
| QADSSRHSQSGQGES | 3836 | P20930 | |
| AGANVHATTATGDTA | 586 | O75179 | |
| GSVSQRGSIGSHQSV | 476 | O60312 | |
| GGFSSTQDTVVALHA | 1246 | P01023 | |
| VQGSTSIFASGSELH | 1431 | Q96SN8 | |
| QGQVSSLSHLNSSGS | 341 | P43699 | |
| QGGFSSTQDTVVALH | 1251 | P20742 | |
| GTATLHVQASGTLSA | 1851 | P98160 | |
| QDSTFNTTSNGILSH | 81 | Q2KHR3 | |
| LYGSTQAHGEQSSNS | 71 | O43251 | |
| SVSSSAALGTLHQGT | 436 | Q16676 | |
| HFNTLDVGASGLNTS | 391 | Q99743 | |
| EGQRTFGSSAHKTQT | 2351 | Q01484 | |
| FSSEGSSEIFQVNGH | 1051 | Q6IE37 | |
| TNTATTTVVANLGGH | 1026 | P51610 | |
| VVTNVGTTGSAFESH | 4831 | Q8WXI7 | |
| TLSQGGTHSTVTQGF | 5291 | Q8WXI7 | |
| NTAVTNVGTSGSGHK | 5421 | Q8WXI7 | |
| NVGTSGSGHKSQSSV | 5426 | Q8WXI7 | |
| TTLFQGGTHSTVSQG | 5586 | Q8WXI7 | |
| TNTAVANVGTSISGH | 5716 | Q8WXI7 | |
| ANVGTSISGHESQSS | 5721 | Q8WXI7 | |
| TAATNVETTSSGHGS | 6886 | Q8WXI7 | |
| VTATNVSAHGSQANS | 311 | P40424 | |
| STSFEQHGTGLSQSS | 426 | Q5D862 | |
| QTCGQHESTSSQSLG | 451 | Q5D862 | |
| SSSGQTSGFGQHELS | 711 | Q5D862 | |
| TSGFGQHELSSGQSS | 716 | Q5D862 | |
| TTSFGQHVSGSDNFS | 1176 | Q5D862 | |
| SDNFSSSGQHISDSG | 1186 | Q5D862 | |
| SSGQHISDSGQSTGF | 1191 | Q5D862 | |
| ISSTAESFHKQNGTG | 61 | Q12913 | |
| VGSSGFSHFNSSNEE | 351 | Q96JY0 | |
| GAQTITSGHSFSSAT | 1601 | Q5T1H1 | |
| GNFSSSVSKVQSHGV | 126 | Q5T3J3 | |
| QENQGHISSSLAASS | 621 | Q4ZG55 | |
| SGVFAASGADHQITQ | 366 | Q9BQ67 | |
| NGHTNTSTGFTAQLK | 96 | Q2M2H8 | |
| SSDQEGNNISSSSGH | 276 | Q8IWI9 | |
| TLFGNQSTDDHGITS | 521 | Q8IZA0 | |
| GITQSLNSGFAQTLH | 501 | Q03001 | |
| GFHLAQQASASGSVS | 461 | Q03252 | |
| QNVNISGGTFTLSHG | 26 | P06681 | |
| ASGHFTGSNVEDRSS | 41 | P15884 | |
| TTQSFGSNAEGQHSG | 246 | Q96PV6 | |
| SSGVSHSSSVQTLGF | 61 | O60318 | |
| SHTATSGGQQGITLT | 701 | O15550 | |
| LATQAHGVSTLGNSS | 71 | Q9Y2U2 | |
| VSQQRHGGSASSVSA | 146 | Q08397 | |
| TNVVTGHQQSFGTSS | 211 | Q8NA75 | |
| GHQQSFGTSSDVLAQ | 216 | Q8NA75 | |
| SSVIASGSSVGHNNL | 521 | Q86X55 | |
| AAAGSGSNSQLLHFS | 1916 | Q9P219 | |
| RTFDANTGNHDVASG | 221 | Q9BXJ5 | |
| SSGLSGTQDCSFQHS | 21 | P49771 | |
| GNNHSFSTANGLSVD | 351 | P55316 | |
| HSQGTTIGFIAFSTN | 171 | P07098 | |
| SQSGTSQAAAHVAGI | 381 | Q8NBP7 | |
| GVAISFSLTAEHSGN | 431 | Q96RD9 | |
| INSATSHSSIGSGND | 1676 | Q8IVL0 | |
| AVTLGTTSNNEGGHF | 386 | Q8IUI8 | |
| DVQFTFSVSNQHGGT | 746 | Q5H8C1 | |
| GQHGSTSGQSSTFDQ | 1311 | Q86YZ3 | |
| GQHGSTSGQSSTFDQ | 1781 | Q86YZ3 | |
| GQHGSTSGQSSTFDQ | 2251 | Q86YZ3 | |
| GQHGSTSGQSSTFDQ | 2721 | Q86YZ3 | |
| HVTDFFTGSDSIQGT | 696 | Q9ULK4 | |
| TSQDTGNSGSVEHPF | 761 | Q96JK2 | |
| SVQDSGSLHNSSSGE | 1056 | Q9HD67 | |
| TGATGVNADSSRSHA | 416 | Q5T7B8 | |
| HSGSFTITGNNSNFA | 91 | P32004 | |
| IETAQQTTTFTGHSG | 171 | Q9HAV0 | |
| GNRTEVGNHSSKSST | 401 | P48169 | |
| GSAQVTSHDASTNGL | 531 | P06744 | |
| STIGFGDLVSSQNAH | 236 | Q9HB14 | |
| HQTSTLARDNEFSGG | 376 | Q9HB14 | |
| HTVNGFVSDFSTGSV | 296 | Q6ZVL6 | |
| TQFSDSTVQSGGSHT | 486 | Q9ULI3 | |
| TTTTNGNGSSEVHIT | 1131 | Q9NQV6 | |
| SSGFSVRSQSLHSVG | 111 | Q9P242 | |
| SSEGSSEIQFNGHNR | 1256 | Q6IE36 | |
| HSSNNFGAILSSTNV | 51 | P10997 | |
| SASQQHSAAGATISA | 141 | P14859 | |
| GNSVSLEFSTNHGRS | 586 | P78509 | |
| EGFSGNTTLFSCSHN | 111 | P48551 | |
| IGSINASVHTGFTFS | 151 | Q8NH89 | |
| VNRSSASSSHFGAVG | 56 | P09067 | |
| TLGHNTQTSIAQDFS | 91 | P09630 | |
| GTSNVGTSGDHDNSF | 76 | A0JP26 | |
| HGRASATSVSSAGEQ | 136 | Q9BZ23 | |
| LQSEVSFSVGGRHSS | 641 | O43182 | |
| SGSVLEQGSASSSQH | 261 | O15488 | |
| HSQQVVDSGFSDLGS | 1541 | Q92794 | |
| THFSNQNSGIIFSSV | 126 | Q9BXJ4 | |
| STGATANHGTSAVAI | 561 | O60353 | |
| QSGFSLSGSQADDHI | 536 | O14531 | |
| GGIISNQQITASSTH | 166 | O43854 | |
| STSSGQHGGRVNLVF | 346 | P0CG42 | |
| ARAGTLSTTGHSTNF | 4116 | Q9C0G6 | |
| NSSQSTHITEQGSQG | 536 | Q96SD1 | |
| STNGGFQSQTAIKHA | 1241 | Q96BY6 | |
| TNQREAASHGFGKTS | 256 | P51587 | |
| SSFQNVGNKVDHSST | 391 | A2CJ06 | |
| SLQSEGHFSLQSSQG | 1201 | Q14CM0 | |
| GHFSLQSSQGSSVDA | 1206 | Q14CM0 | |
| EESTGFLGNISSASH | 156 | Q2WGN9 | |
| LTVFGGVNSSSHTGT | 61 | P06241 | |
| LFTQSHGVSLSTGSG | 331 | Q12934 | |
| QSDNESVQSGRSHSG | 1101 | Q6PD62 | |
| SVQSGRSHSGVSEND | 1106 | Q6PD62 | |
| QSTGRQFDSSTFGGH | 741 | P00519 | |
| TGFHLTTTNQGASAA | 761 | Q9UQ88 | |
| SVLQGTGASQSCHSA | 76 | Q674R7 | |
| HLNSRDSGFSSGNTD | 651 | Q9NYL2 | |
| NGHSTDTLTGSGFRV | 96 | Q9NS15 | |
| TAGREFSGQVSHQTT | 1206 | Q8TEP8 | |
| QDTSHLTSGSVSGLA | 3321 | Q03164 | |
| LSEHAGSSNAFTSGE | 131 | P14735 | |
| TRNSILQGSVHTGFS | 356 | O95834 | |
| FHTAAAGIVQNLSTG | 1391 | Q6ZMW3 | |
| GASFNLSLTAEHSGN | 351 | Q96LA5 | |
| HTDSNTVLGQNDTGF | 426 | Q9BX70 | |
| QHSASEEGGNFSSSS | 256 | D6RIA3 | |
| VTQTRGATETASQGH | 26 | P39059 | |
| QDSQEGTFGSEHSAS | 331 | Q9UPN6 | |
| LFGDNHNGLTSSSAS | 166 | P51168 | |
| TQNGTNFTSDSHFSG | 186 | A6NLW8 | |
| FDANTGNHDVASGST | 221 | Q9BXJ2 | |
| GSSLASQVHAAAVNG | 11 | Q9Y283 | |
| LQGSVSSGQAHSLTS | 341 | Q99558 | |
| GTSNVGTSGDHDNSF | 76 | B2RU33 | |
| SQHVRTGSAANTATG | 56 | Q685J3 | |
| GTSNVGTSGDHENSF | 76 | Q86YR6 | |
| TGFHETSNINDFSAG | 301 | P15104 | |
| VATGATHTGLSTFQN | 1026 | Q96Q06 | |
| SGGNEKQVTTISHSS | 536 | Q92750 | |
| TNFEGSQSQDHSGIF | 401 | Q7RTN6 | |
| SQSQDHSGIFGLVTN | 406 | Q7RTN6 | |
| NTQEGAVQNHGTSTS | 226 | Q8N3S3 | |
| GGHSSQEIKSETSSN | 596 | Q684P5 | |
| AGNSTARILSTNHTG | 46 | Q14542 | |
| VSQAGSQQSSHLSVD | 446 | Q8IYX7 | |
| SSGSSQTSVQSQVHG | 971 | Q6IEE7 | |
| ATAAATNHTTDNGVG | 51 | Q15046 | |
| GIGSVSAASNSASVH | 441 | Q8N4F4 | |
| ASGAGGQHVNTTDSA | 246 | Q9UGC7 | |
| QGHLANSLETSGSFS | 426 | Q5QGS0 | |
| FQASGLSSTGSEVHQ | 111 | Q92786 | |
| GTVTNGSVCSVHSVN | 381 | Q15678 | |
| EQHQRTSSGTSIAGN | 31 | Q9NZC9 | |
| SRTNFSSHTNQSGGS | 251 | Q9Y252 | |
| VRNSQSFDSSLHGAG | 426 | Q8ND83 | |
| NGTSLGFVNSHLTSG | 531 | Q92835 | |
| QGSSNSVSDTGAHGV | 1101 | Q9C0A6 | |
| AISFVDQGGHVLSST | 536 | Q14940 | |
| GSRTQHLEGTGTFTT | 1576 | Q9C0D5 | |
| SHGQASITTDDGVVF | 1346 | O75592 | |
| TNSSLSLHVGGSNLS | 1311 | P08F94 | |
| NSTSSAGNTALHVAV | 311 | O60733 | |
| GSGNTLHSDSIASAQ | 856 | Q9NZP6 | |
| AAESFNGNETLGHSS | 261 | O94818 | |
| SGFHSTLAAGEVTNG | 161 | P0CG40 | |
| STNLGVNQAGFTLHS | 211 | P35611 | |
| FGTFNTSQSHQTASA | 296 | P52594 | |
| ASGANVHATTATGDT | 556 | Q8IWZ3 | |
| SLNSVSSSAHNGFEG | 221 | O15516 | |
| SSSAHNGFEGTIQRT | 226 | O15516 | |
| EVLGFGLGSSTSTQH | 836 | Q2KHT3 | |
| HFKEGSSQSESGSQR | 296 | Q9NZR4 | |
| SSTAQGNTEVIHTGT | 6 | Q8N8H1 | |
| GNSTHGCSSEETFLI | 221 | Q03405 | |
| NSTSSNSDSGIGNFH | 416 | O14924 | |
| SGAGSTLHDNVFTST | 471 | P40200 | |
| TGSSTRHIVTFDGQN | 1951 | P04275 | |
| QGSLFHSGTASSSQN | 481 | Q96MK2 | |
| LTTSSGQVHSSDLQG | 356 | Q02447 | |
| ETSVNQDTGRGGFHT | 181 | Q7Z6K1 | |
| RGSAVATSHFEVGNT | 1756 | Q92576 | |
| TVLSTTCFHSEEGGQ | 766 | O43151 | |
| SSQASTGSTQLQLHG | 926 | Q86YV5 | |
| NGGSFEEVLSSTAHA | 171 | Q16890 | |
| NLTSTASSGTNVHGS | 416 | Q8IYT8 | |
| TGQGNTEAFHTGTLQ | 61 | P17035 | |
| HAGSFNATGQQKDTS | 26 | Q64LD2 | |
| HVGSAQQVRTGSTSS | 351 | Q5T4S7 | |
| SQSENTFLGTSASHG | 596 | Q9C0B0 | |
| STFGVGLENVSNVST | 3376 | Q9Y4A5 | |
| TSHGQSSQGIVEETS | 396 | Q96RL1 | |
| VVGSSSNNVGHGSST | 296 | Q8NDV7 | |
| FSNHSGNLLGIITSN | 486 | Q2T9J0 | |
| VVGSGQLFSHSSSDA | 226 | Q9Y473 | |
| NSSNEHVISIGASFS | 1271 | Q7Z3T8 | |
| AVHASTSGSGALTDQ | 41 | Q6UXV3 | |
| HSQGTTIAFIAFSTN | 171 | Q5VXJ0 | |
| AAVFGGTQSLHTNSF | 376 | P22033 | |
| TSGHGSRNSQLGIFS | 61 | O14777 |